Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva.
Williams E, Bagarova J, Kerr G, Xia DD, Place ES, Dey D, Shen Y, Bocobo GA, Mohedas AH, Huang X, Sanderson PE, Lee A, Zheng W, Economides AN, Smith JC, Yu PB, Bullock AN.
Williams E, et al. Among authors: smith jc.
JCI Insight. 2021 Apr 22;6(8):e95042. doi: 10.1172/jci.insight.95042.
JCI Insight. 2021.
PMID: 33705358
Free PMC article.